Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Phase 1
- Conditions
- Meningococcal MeningitisMeningitisMeningococcal Infections
- Interventions
- Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free)Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant)
- First Posted Date
- 2016-09-29
- Last Posted Date
- 2016-09-29
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 360
- Registration Number
- NCT02919293
- Locations
- 🇨🇳
Gaozhou Center for Disease Control and Prevention, Gaozhou, Guangdong, China
Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
Phase 1
- Conditions
- Meningitis, Meningococcal
- Interventions
- Biological: Meningococcal ACYW135 Polysaccharide Conjugate Vaccine
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2016-08-26
- Lead Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT02878291
- Locations
- 🇨🇳
Sanjiang Center for Disease Control and Prevention, Sanjiang, Guangxi, China
© Copyright 2025. All Rights Reserved by MedPath